EuBiologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9,897	9,897	11,044	6,535	53,088
Short-Term Investments	1,594	1,594	180	25,139	1,786
Cash & Short-Term Investments	11,491	11,491	11,224	31,673	54,874
Cash Growth	2.38%	2.38%	-64.56%	-42.28%	-
Accounts Receivable	5,890	5,890	3,190	2,569	2,657
Other Receivables	2,526	2,526	41.71	147.08	612.9
Receivables	8,628	8,628	3,524	3,007	4,354
Inventory	13,342	13,342	18,013	14,776	9,252
Prepaid Expenses	1,065	1,065	1,210	1,052	701.04
Other Current Assets	7,238	7,238	7,168	3,211	2,225
Total Current Assets	41,764	41,764	41,139	53,720	71,407
Property, Plant & Equipment	70,096	70,096	72,815	70,046	68,538
Long-Term Investments	15,410	15,410	17,399	13,163	8,632
Goodwill	888.92	888.92	888.92	888.92	888.92
Other Intangible Assets	2,593	2,593	1,650	851.31	637.97
Long-Term Deferred Tax Assets	5,538	5,538	5,273	5,372	2,577
Long-Term Deferred Charges	14,089	14,089	21,686	4,033	2,394
Other Long-Term Assets	1,313	1,313	861.6	1,922	258.97
Total Assets	151,806	151,806	162,066	150,438	155,955
Accounts Payable	635.71	635.71	856.17	308.15	198.96
Accrued Expenses	1,293	1,293	3,885	2,640	2,615
Short-Term Debt	8,656	8,656	8,500	2,500	4,500
Current Portion of Long-Term Debt	800	800	400	6,000	-
Current Portion of Leases	976.59	976.59	1,033	801.87	698.07
Current Income Taxes Payable	998.09	998.09	-	-	-
Other Current Liabilities	12,339	12,339	9,950	5,032	27,185
Total Current Liabilities	25,699	25,699	24,624	17,282	35,197
Long-Term Debt	2,800	2,800	3,600	4,000	14,965
Long-Term Leases	1,546	1,546	2,129	2,219	2,408
Other Long-Term Liabilities	16,148	16,148	11,760	9,673	6,509
Total Liabilities	46,988	46,988	42,631	33,175	59,079
Common Stock	18,227	18,227	18,222	18,137	17,433
Additional Paid-In Capital	223,103	223,103	220,859	219,542	171,522
Retained Earnings	-135,103	-135,103	-121,224	-120,125	-92,551
Comprehensive Income & Other	5,145	5,145	6,652	2,445	472.1
Total Common Equity	111,373	111,373	124,510	119,999	96,877
Minority Interest	-6,555	-6,555	-5,075	-2,736	-
Shareholders' Equity	104,818	104,818	119,435	117,263	96,877
Total Liabilities & Equity	151,806	151,806	162,066	150,438	155,955
Total Debt	14,779	14,779	15,663	15,521	22,571
Net Cash (Debt)	-3,287	-3,287	-4,439	16,152	32,303
Net Cash Growth	-	-	-	-50.00%	-
Net Cash Per Share	-90.19	-90.19	-121.93	455.63	1152.93
Filing Date Shares Outstanding	36.45	36.45	36.44	36.27	34.87
Total Common Shares Outstanding	36.45	36.45	36.44	36.27	34.87
Working Capital	16,065	16,065	16,514	36,438	36,210
Book Value Per Share	3055.10	3055.10	3416.39	3308.10	2778.58
Tangible Book Value	107,891	107,891	121,971	118,259	95,350
Tangible Book Value Per Share	2959.59	2959.59	3346.72	3260.12	2734.79
Land	5,435	5,435	5,435	5,435	5,435
Buildings	30,819	30,819	30,642	31,867	31,727
Machinery	47,586	47,586	41,374	36,630	32,484
Construction In Progress	11,642	11,642	14,444	9,376	6,711

Source: S&P Capital IQ. Standard template. Financial Sources.